This regulatory milestone follows news from earlier this year, when the company announced positive verification study results for its Nellcor™ pulse oximetry system with Nell-EQ™ intelligent processor ...
The TCM5 FLEX transcutaneous monitor is a compact, easy-to-use solution that delivers accurate and continuous measurement of oxygenation (tcpO2) and ventilation (tcpCO2) status in neonatal, pediatric ...
Introduction To better identify severe hypoxaemia as a major risk factor for specific illnesses in children aged under 5 years, the Améliorer l’Identification des détresses Respiratoires chez l’Enfant ...
The newly cleared capability uses AI through the smartSET pulse oximetry sensor platform.
That’s where pulse oximeters come in. These small devices measure your heart rate and SpO₂. They give you another way to understand how your body responds during exercise and recovery. Also, they may ...
The Indus Rodent Surgical Monitor is a sophisticated, all-in-one solution for surgical warming and vital signs monitoring tailored for preclinical research involving mice, rats, and other small ...
The Fitbit Air and Fitbit Charge 6 are two of the best fitness trackers in 2026. But is one better than the other? That truly depends on your budget, the number of smart features, and the type of user ...
Advancements in technology and broadband have revolutionized the current practice of medicine. The field of pediatric cardiology is no exception given the need for prompt diagnosis and reliance on ...
The OIRD detection capability [Image courtesy of Masimo] Masimo, a Danaher (NYSE:DHR) company, today announced FDA clearance for an opioid-induced respiratory depression (OIRD) detection platform.
Neonates and infants have been referred to as ‘therapeutic orphans’ due to the overall scarcity of treatments that have been developed and tailored to their needs. However, in recent years there have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results